Formulation of aspirin nanoparticles using solvent evaporation method and in vivo evaluation of its antithrombotic effect

Lara Alhajj; Collins Ovenseri Airemwen; Leyla Beba Pozharani

doi:10.36721/PJPS.2023.36.5.SP.1583-1589.1

original articles

Formulation of aspirin nanoparticles using solvent evaporation method and in vivo evaluation of its antithrombotic effect

Lara Alhajj, Collins Ovenseri Airemwen, Leyla Beba Pozharani

Vol. 36

Issue 5

Pages 1583-1589

Published 01 Sept 2023

DOI: 10.36721/PJPS.2023.36.5.SP.1583-1589.1

Authors Abstract Related

Authors & Affiliations

Lara Alhajj

Collins Ovenseri Airemwen

Leyla Beba Pozharani

Abstract

Nanotechnology offers several advantages in the treatment of chronic diseases through site-specific and target-oriented drug delivery

Keywords

Aspirin

nanoparticles

myocardial infarction

thrombosis

Metrics

PlumX Metrics

original articles

Formulation of aspirin nanoparticles using solvent evaporation method and in vivo evaluation of its antithrombotic effect

Lara Alhajj, Collins Ovenseri Airemwen, Leyla Beba Pozharani

Vol. 36

Issue 5

Pages 1583-1589

Published 01 Sept 2023

DOI: 10.36721/PJPS.2023.36.5.SP.1583-1589.1

Authors Abstract Related

Authors & Affiliations

Lara Alhajj

Collins Ovenseri Airemwen

Leyla Beba Pozharani

Abstract

Nanotechnology offers several advantages in the treatment of chronic diseases through site-specific and target-oriented drug delivery

Keywords

Aspirin

nanoparticles

myocardial infarction

thrombosis

Metrics

PlumX Metrics

Formulation of aspirin nanoparticles using solvent evaporation method and in vivo evaluation of its antithrombotic effect

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Formulation of aspirin nanoparticles using solvent evaporation method and in vivo evaluation of its antithrombotic effect

Authors & Affiliations

Abstract

Keywords

Metrics